Quick View: FDA’s Approval Of Dexcom’s Over-The-Counter Stelo Glucose Biosensor System Will Expand Access To Diabetes Management Devices
Healthcare / United States / Thu 07 Mar, 2024
The Latest: On March 5 2024, the US Food and Drug Administration (FDA) approved Dexcom’s Stelo Glucose Biosensor System, marking the first FDA approval of an over the counter (OTC) continuous glucose monitor (CGM). The device is an integrated CGM that is to be worn on the upper arm and lasts for up to 15 days before it needs to be replaced. It